Pharmaceutical Supply chain Risk Assessment During COVID-19 Epidemic

The global health products supply chain is negatively influenced by the COVID-19 pandemic. Moreover, the risks in the pharmaceutical supply chain (PSC) have increased. Assessment and mitigation risks in PSC are essential issues to control and counter these risks. In this study, a 2-Tuple ARAS-BWM ap...

Descripción completa

Detalles Bibliográficos
Autores principales: BenAmor, W. Daoud, Labella, A., Frikha, H. Moalla, López, L. Martínez
Formato: Online Artículo Texto
Lenguaje:English
Publicado: , IFAC (International Federation of Automatic Control) Hosting by Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605720/
http://dx.doi.org/10.1016/j.ifacol.2022.10.035
_version_ 1784818135620124672
author BenAmor, W. Daoud
Labella, A.
Frikha, H. Moalla
López, L. Martínez
author_facet BenAmor, W. Daoud
Labella, A.
Frikha, H. Moalla
López, L. Martínez
author_sort BenAmor, W. Daoud
collection PubMed
description The global health products supply chain is negatively influenced by the COVID-19 pandemic. Moreover, the risks in the pharmaceutical supply chain (PSC) have increased. Assessment and mitigation risks in PSC are essential issues to control and counter these risks. In this study, a 2-Tuple ARAS-BWM approach, which combines ARAS and BWM methods under linguistic 2-Tuple environment, is proposed to evaluate and address various risks to the best mitigation strategies in the pharmaceutical industry in Tunisia during COVID-19. Noted that the main risk identified in the PSC is related to supply and suppliers and its best mitigation strategy is reducing risk.
format Online
Article
Text
id pubmed-9605720
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher , IFAC (International Federation of Automatic Control) Hosting by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-96057202022-10-27 Pharmaceutical Supply chain Risk Assessment During COVID-19 Epidemic BenAmor, W. Daoud Labella, A. Frikha, H. Moalla López, L. Martínez IFAC-PapersOnLine Article The global health products supply chain is negatively influenced by the COVID-19 pandemic. Moreover, the risks in the pharmaceutical supply chain (PSC) have increased. Assessment and mitigation risks in PSC are essential issues to control and counter these risks. In this study, a 2-Tuple ARAS-BWM approach, which combines ARAS and BWM methods under linguistic 2-Tuple environment, is proposed to evaluate and address various risks to the best mitigation strategies in the pharmaceutical industry in Tunisia during COVID-19. Noted that the main risk identified in the PSC is related to supply and suppliers and its best mitigation strategy is reducing risk. , IFAC (International Federation of Automatic Control) Hosting by Elsevier Ltd. 2022 2022-10-26 /pmc/articles/PMC9605720/ http://dx.doi.org/10.1016/j.ifacol.2022.10.035 Text en © 2019, IFAC (International Federation of Automatic Control) Hosting by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
BenAmor, W. Daoud
Labella, A.
Frikha, H. Moalla
López, L. Martínez
Pharmaceutical Supply chain Risk Assessment During COVID-19 Epidemic
title Pharmaceutical Supply chain Risk Assessment During COVID-19 Epidemic
title_full Pharmaceutical Supply chain Risk Assessment During COVID-19 Epidemic
title_fullStr Pharmaceutical Supply chain Risk Assessment During COVID-19 Epidemic
title_full_unstemmed Pharmaceutical Supply chain Risk Assessment During COVID-19 Epidemic
title_short Pharmaceutical Supply chain Risk Assessment During COVID-19 Epidemic
title_sort pharmaceutical supply chain risk assessment during covid-19 epidemic
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605720/
http://dx.doi.org/10.1016/j.ifacol.2022.10.035
work_keys_str_mv AT benamorwdaoud pharmaceuticalsupplychainriskassessmentduringcovid19epidemic
AT labellaa pharmaceuticalsupplychainriskassessmentduringcovid19epidemic
AT frikhahmoalla pharmaceuticalsupplychainriskassessmentduringcovid19epidemic
AT lopezlmartinez pharmaceuticalsupplychainriskassessmentduringcovid19epidemic

Ejemplares similares